The MyD88-dependent TLR2 signaling activates NF-κB pathway, which in turn stimulates the transcription of proinflammatory cytokines and chemokines, and may lead to cellular proliferation and tumor progression [55, 112, 113]. This evidence concerns the gene NFKB1 and neoplasm.